Current treatment strategies in mesothelioma
Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy primarily caused by asbestos exposure. Over the past decade, treatment strategies have evolved significantly, incorporating advancements in systemic therapies, immunotherapy, and personalized medicine. Multimodality treatment — integrating surgery, systemic therapy, and radiotherapy — may improve outcomes in carefully selected patients. This manuscript provides an overview of current treatment modalities for pleural mesothelioma (PM), emphasizing recent developments and emerging therapies.
Authors
- Balázs Hegedűs (ORCID: https://orcid.org/0000-0002-4341-4153)
- Natalie Baldes (ORCID: https://orcid.org/0000-0002-8719-2206)
- Maja Guberina (ORCID: https://orcid.org/0000-0003-3218-0539)
- Servet Bölükbas (ORCID: https://orcid.org/0000-0001-8275-5957)
- M Metzenmacher
- Martin Stuschke (ORCID: https://orcid.org/0000-0001-6836-0940)
- Fabian Doerr (ORCID: https://orcid.org/0000-0002-0878-0406)
- Hubertus Hautzel (ORCID: https://orcid.org/0000-0002-3581-5264)
- Konstantinos Grapatsas (ORCID: https://orcid.org/0000-0002-1616-6297)
- N Guberina
- Martin Schuler
Institutions
- Ruhrlandklinik (DE)
- Essen University Hospital (DE)
- West German Heart and Vascular Center Essen (DE)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- Nowotwory Journal of Oncology
- Published
- 2026-04-29
- DOI
- https://doi.org/10.5603/njo.108985
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00